Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 841-854 |
| Number of pages | 14 |
| Journal | European Journal of Physical and Rehabilitation Medicine |
| Volume | 52 |
| Issue number | 6 |
| Publication status | Published - 2016 |
Fingerprint
Keywords
- Brain injuries
- Dementia
- Infectious disease medicine
- Medical oncology
- Motor neuron disease
- Movement disorders
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology: Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation. / Bartolo, M.; Chiò, Adriano; Ferrari, S.; Tassorelli, C.; Tamburin, Stefano; Avenali, M.; Azicnuda, E.; Calvo, Felipe A.; Caraceni, A.T.; DeFazio, G.; De Icco, Roberto; Formisano, R.; Franzoni, S.; Greco, E.; Jedrychowska, I.; Magrinelli, Francesca; Manera, Umberto; Marchioni, E.; Mariotto, Sara; Monaco, S.; Pace, A.; Saviola, Donatella; Springhetti, I.; Tinazzi, M.; De Tanti, Antonio.
In: European Journal of Physical and Rehabilitation Medicine, Vol. 52, No. 6, 2016, p. 841-854.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology: Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation
AU - Bartolo, M.
AU - Chiò, Adriano
AU - Ferrari, S.
AU - Tassorelli, C.
AU - Tamburin, Stefano
AU - Avenali, M.
AU - Azicnuda, E.
AU - Calvo, Felipe A.
AU - Caraceni, A.T.
AU - DeFazio, G.
AU - De Icco, Roberto
AU - Formisano, R.
AU - Franzoni, S.
AU - Greco, E.
AU - Jedrychowska, I.
AU - Magrinelli, Francesca
AU - Manera, Umberto
AU - Marchioni, E.
AU - Mariotto, Sara
AU - Monaco, S.
AU - Pace, A.
AU - Saviola, Donatella
AU - Springhetti, I.
AU - Tinazzi, M.
AU - De Tanti, Antonio
N1 - Cited By :1 Export Date: 24 March 2017 Correspondence Address: De Tanti, A.; Centro Cardinal Ferrari, Via 4 Novembre 21, Italy; email: antonio.detanti@centrocardinalferrari.it References: Tamburin, S., Paolucci, S., Magrinelli, F., Musicco, M., Sandrini, G., The Italian Consensus Conference on Pain in Neurorehabilitation. Rationale and Methodology (2016) J Pain Res, 9, pp. 311-318; Ford, B., Pain in Parkinson's disease (2010) Mov Disord, 25, pp. S98-S103; Tison, F., Wenning, G.K., Volonte, M.A., Poewe, W.R., Henry, P., Quinn, N.P., Pain in multiple system atrophy (1996) J Neurol, 243, pp. 153-156; Chan, J., Brin, M.F., Fahn, S., Idiopathic cervical dystonia: Clinical characteristics (1991) Mov Disord, 6, pp. 119-126; Defazio, G., Berardelli, A., Fabbrini, G., Martino, D., Fincati, E., Fiaschi, A., Pain as a nonmotor symptom of Parkinson's disease: Evidence from a case-control study (2008) Arch Neurol, 65, pp. 1191-1194; Ford, B., Pain in Parkinson's disease (1998) Clin Neurosci, 5, pp. 63-72; Negre-Pages, L., Regragui, W., Bouhassira, D., Grandjean, H., Rascol, O., Chronic pain in Parkinson's disease: The cross-sectional French DoPaMiP survey (2008) Mov Disord, 23, pp. 1361-1369; Defazio, G., Gigante, A., Mancino, P., Tinazzi, M., The epidemiology of pain in Parkinson's disease (2013) J Neural Transm, 120, pp. 583-586; Perrotta, A., Sandrini, G., Serrao, M., Buscone, S., Tassorelli, C., Tinazzi, M., Facilitated temporal summation of pain at spinal level in Parkinson's disease (2011) Mov Disord, 26, pp. 442-448; Greenbaum, L., Tegeder, I., Barhum, Y., Melamed, E., Roditi, Y., Djaldetti, R., Contribution of genetic variants to pain susceptibility in Parkinson disease (2012) Eur J Pain, 16, pp. 1243-1250; Kutvonen, O., Dastidar, P., Nurmikko, T., Pain in spasmodic torticollis (1997) Pain, 69, pp. 279-286; Lobbezoo, F., Tanguay, R., Thon, M.T., Lavigne, G.J., Pain perception in idiopathic cervical dystonia (spasmodic torticollis) (1996) Pain, 67, pp. 483-491; Tinazzi, M., Rosso, T., Fiaschi, A., Role of the somatosensory system in primary dystonia (2003) Mov Disord, 18, pp. 605-622; Tinazzi, M., Valeriani, M., Squintani, G., Corrà, F., Recchia, S., Defazio, G., Nociceptive pathway function is normal in cervical dystonia: A study using laser-evoked potentials (2012) J Neurol, 259, pp. 2060-2066; Kuyper, D.J., Parra, P., Aerts, S., Okun, M.S., Kluger, B.M., Nonmotor manifestations of dystonia: A systematic review (2011) Mov Disord, 26, pp. 1206-1217; Miller, R.G., Rosenberg, J.A., Gelinas, D.F., Mitsumoto, H., Newman, D., Sufit, R., Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force (1999) Neurology, 52, pp. 1311-1323; Ganzini, L., Johnston, W.S., Hoffman, W.F., Correlates of suffering in amyotrophic lateral sclerosis (1999) Neurology, 52, pp. 1434-1440; Newrick, P.G., Langton-Hewer, R., Pain in motor neuron disease (1985) J Neurol Neurosurg Psychiatry, 48, pp. 838-840; Wu, P.Y., The management of patients with advanced motor neuron disease (1998) Zhonghua Yi Xue Za Zhi, 61, pp. 141-145; Shibata, M., Abe, K., Jimbo, A., Shimizu, T., Mihara, M., Sadahiro, S., Complex regional pain syndrome type I associated with amyotrophic lateral sclerosis (2003) Clin J Pain, 19, pp. 69-70; Drory, V.E., Goltsman, E., Reznik, J.G., Mosek, A., Korczyn, A.D., The value of muscle exercise in patients with amyotrophic lateral sclerosis (2001) J Neurol Sci, 191, pp. 133-137; Rivera, I., Ajroud-Driss, S., Casey, P., Heller, S., Allen, J., Siddique, T., Prevalence and characteristics of pain in early and late stages of ALS (2013) Amyotroph Lateral Scler Frontotemporal Degener, 14, pp. 369-372; Tedman, B.M., Young, C.A., Williams, I.R., Assessment of depression in patients with motor neuron disease and other neurologically disabling illness (1997) J Neurol Sci, 152, pp. S75-S79; Lou, J.S., Reeves, A., Benice, T., Sexton, G., Fatigue and depression are associated with poor quality of life in ALS (2003) Neurology, 60, pp. 122-123; Coleman, M.R., Davis, M.H., Rodd, J.M., Robson, T., Ali, A., Owen, A.M., Pickard, J.D., Towards the routine use of brain imaging to aid the clinical diagnosis of disorders of consciousness (2009) Brain, 132, pp. 2541-2552; Laureys, S., Faymonville, M.E., Peigneux, P., Damas, P., Lambermont, B., Del Fiore, G., Cortical processing of noxious somatosensory stimuli in the persistent vegetative state (2002) Neuroimage, 17, pp. 732-741; Kassubek, J., Juengling, F.D., Els, T., Spreer, J., Herpers, M., Krause, T., Activation of a residual cortical network during painful stimulation in long-term postanoxic vegetative state: A 15O-H2O PET study (2003) J Neurol Sci, 212, pp. 85-91; Boly, M., Faymonville, M.E., Schnakers, C., Peigneux, P., Lambermont, B., Phillips, C., Perception of pain in the minimally conscious state with PET activation: An observational study (2008) Lancet Neurol, 7, pp. 1013-1020; Owen, A.M., Schiff, N., Laureys, S., The assessment of conscious awareness in the vegetative state (2009) The Neurology of Consciousness, pp. 163-172. , Laureys S, Tononi G, editors. London: Elsevier; De Tanti, A., Saviola, D., Riabilitazione della persona con esiti di trauma cranio-encefalico (TCE) e di grave cerebrolesione acquisita (GCA) EMC (Elsevier Masson SAS, Paris) (2008) Medicina Riabilitativa, , 26-455-D-15; Formisano, R., Bivona, U., Catani, S., D'Ippolito, M., Buzzi, M.G., Posttraumatic headache: Facts and doubts (2009) J Headache Pain, 10, pp. 145-152; Celik, C., Ucan, H., Alemdaroglu, E., Oktay, F., Critical illness polyneuropathy: A case report (2011) Neuro Rehabil, 29, pp. 229-232; Pistoia, F., Sacco, S., Sarà, M., Carolei, A., The perception of pain and its management in disorders of consciousnes (2013) Curr Pain Headache Rep, 17, p. 374; Bruehl, S., An update on the pathophysiology of complex regional pain syndrome (2010) Anesthesiology, 113, pp. 713-725; Cole, L.J., Farrell, M.J., Duff, E.P., Barber, J.B., Egan, G.F., Gibson, S.J., Pain sensitivity and fMRI pain-related brain activity in Alzheimer's disease (2006) Brain, 129, pp. 2957-2965; Greicius, M.D., Krasnow, B., Reiss, A.L., Menon, V., Functional connectivity in the resting brain: A network analysis of the default mode hypothesis (2003) Proc Natl Acad Sci USA, 100, pp. 253-258; Pharmacological Management of Persistent Pain in Older Persons (2009) J Am Geriatr Soc, 57, pp. 1331-1346. , American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons; Cognitive impairment in chronic pain (2007) Pain. Clinical Updates, 15 (4). , International Association for the study of pain - IASP; Guidance on the management of pain in older people (2013) Age Ageing, 42, pp. i1-i57. , British Geriatrics Society; Cavaletti, G., Cornblath, D.R., Merkies, I.S., Postma, T.J., Rossi, E., Frigeni, B., The chemotherapy-induced peripheral neuropathy outcome measures standardization study: From consensus to the first validity and reliability findings (2013) Ann Oncol, 24, pp. 454-462; Kahn, K., Finkel, A., It IS a tumor-current review of headache and brain tumor (2014) Curr Pain Headache Rep, 18, p. 421; Taylor, L.P., Mechanism of brain tumor headache (2014) Headache, 54, pp. 772-775; Fainsinger, R.L., Nekolaichuk, C.L., Cancer pain assessment - Can we predict the need for specialist input? (2008) Eur J Cancer, 44, pp. 1072-1077; Fainsinger, R.L., Fairchild, A., Nekolaichuk, C., Lawlor, P., Lowe, S., Hanson, J., Is pain intensity a predictor of the complexity of cancer pain management? (2009) J Clin Oncol, 27, pp. 585-590; Hao, S., The molecular and pharmacological mechanisms of HIV-related neuropathic pain (2013) Curr Neuropharmacol, 11, pp. 499-512; Chaudhuri, K.R., Rizos, A., Trenkwalder, C., Rascol, O., Pal, S., Martino, D., King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation (2015) Mov Disord, 30, pp. 1623-1631; Tinazzi, M., Recchia, S., Simonetto, S., Defazio, G., Tamburin, S., Moretto, G., Hyperalgesia and laser evoked potentials alterations in hemiparkinson: Evidence for an abnormal nociceptive processing (2009) J Neurol Sci, 276, pp. 153-158; Jost, W.H., Hefter, H., Stenner, A., Reichel, G., Rating scales for cervical dystonia: A critical evaluation of tools for outcome assessment of botulinum toxin therapy (2013) J Neural Transm, 120, pp. 487-496. , Vienna; Boyce, M.J., Canning, C.G., Mahant, N., Morris, J., Latimer, J., Fung, V.S., The Toronto Western Spasmodic Torticollis Rating Scale: Reliability in neurologists and physiotherapists (2012) Parkinsonism Relat Disord, 18, pp. 635-637; Evidente, V.G., Fernandez, H.H., LeDoux, M.S., Brashear, A., Grafe, S., Hanschmann, A., A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia (2013) J Neural Transm, 120, pp. 1699-1707. , Vienna; Chiò, A., Canosa, A., Gallo, S., Moglia, C., Ilardi, A., Cammarosano, S., Pain in amyotrophic lateral sclerosis: A population-based controlled (2012) Eur J Neurol, 19, pp. 551-555; Pagnini, F., Lunetta, C., Banfi, P., Rossi, G., Fossati, F., Marconi, A., Pain in Amyotrophic Lateral Sclerosis: A psychological perspective (2012) Neurol Sci, 33, pp. 1193-1196; Adelman, E.E., Albert, S.M., Rabkin, J.G., Del Bene, M.L., Tider, T., O'Sullivan, I., Disparities in perceptions of distress and burden in ALS patients and family caregivers (2004) Neurology, 62, pp. 1766-1770; Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms (2009) Task Force on Taxonomy, , International Association for the study of pain - IASP vol; Warden, V., Hurley, A.C., Volicer, L., Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAI NAD) scale (2003) J Am Med Dir Assoc, 4, pp. 9-15; Schnakers, C., Chatelle, C., Vanhaudenhuyse, A., Majerus, S., Ledoux, D., Boly, M., The Nociception Coma Scale: A new tool to assess nociception in disorders of consciousness (2010) Pain, 148, pp. 215-219; Sattin, D., Pagani, M., Covelli, V., Giovannetti, A.M., Leonardi, M., The Italian version of the Nociception Coma Scale (2013) Int J Rehabil Res, 36, pp. 182-186; Chatelle, C., Majerus, S., Whyte, J., Laureys, S., Schnakers, C., A sensitive scale to assess nociceptive pain in patients with disorders of consciousness (2012) J Neurol Neurosurg Psychiatry, 83, pp. 1233-1237; Licht, E., Siegler, E.L., Reid, M.C., Can the cognitively impaired safely use patient-controlled analgesia? (2009) J Opioid Manag, 5, pp. 307-312; Zwakhalen, S.M., Van Der Steen, J.T., Najim, M.D., Which score most likely represents pain on the observational PAI NAD pain scale for patients with dementia? (2013) J Am Med Dir Assoc, 13, pp. 384-389; Downie, W.W., Leatham, P.A., Rhind, V.M., Wright, V., Branco, J.A., Anderson, J.A., Studies with pain rating scales (1978) Ann Rheum Dis, 37, pp. 378-381; Melzack, R., The McGill Pain Questionnaire: Major properties and scoring methods (1975) Pain, 1, pp. 277-299; Cleeland, C.S., Ryan, K.M., Pain assessment: Global use of the Brief Pain Inventory (1994) Ann Acad Med Singapore, 23, pp. 129-138; Jensen, M.P., The validity and reliability of pain measures in adults with cancer (2003) J Pain, 4, pp. 2-21; Venkataramana, A.B., Skolasky, R.L., Creighton, J.A., McArthur, J.C., Diagnostic utility of the subjective peripheral neuropathy screen in HIV-infected persons with peripheral sensory polyneuropathy (2005) AIDS Read, 5, pp. 341-344; McArthur, J.H., The reliability and validity of the subjective peripheral neuropathy screen (2005) J Assoc Nurses AIDS Care, 9, pp. 84-94; Cherry, C.L., Wesselingh, S.L., Lal, L., McArthut, J.C., Evaluation of a clinical for HIV-associated sensory neuropathies (2005) Neurology, 65, pp. 1778-1781; Bouhassira, D., Attal, N., Willer, J.C., Brasseur, L., Painful and painless peripheral sensory neuropathies due to HIV infection: A comparison using quantitative sensory evaluation (1999) Pain, 80, pp. 265-272; Ng, L., Talman, P., Khan, F., Motor neuron disease: Disability profile and service needs in an Australian cohort (2011) Int J Rehabil Res, 34, pp. 151-159; Jensen, M.P., Abresch, R.T., Carter, G.T., The Reliability and Validity of a Self-Report Version of the FIM Instrument in Persons With Neuromuscular Disease and Chronic Pain (2005) Arch Phys Med Rehabil, 86, pp. 1155-1163; Blatzheim, K., Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosis (2009) J Bodyw Mov Ther, 13, pp. 328-335; Preyde, M., Effectiveness of massage therapy for subacute low-back pain: A randomized controlled trial (2000) CMAJ, 162, pp. 1815-1820; Baguley, I.J., Perkes, I.E., Fernandez-Ortega, J.F., Rabinstein, A.A., Dolce, G., Hendricks, H.T., Paroxysmal sympathetic hyperactivity after acquired brain injury: Consensus on conceptual definition, nomenclature, and diagnostic criteria (2014) J Neurotrauma, 31, pp. 1515-1520; American Pain Society Guideline for the management on pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis (2002) Clinical Practice Guideline, (2). , Glenview, IL: American Pain Society; Cheville, A.L., Pain management in cancer rehabilitation (2001) Arch Phys Med Rehabil, 82, pp. S84-S87; Khan, F., Amatya, B., Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour (2013) J Neurooncol, 111, pp. 355-366; Silver, J.K., Baima, J., Newman, R., Galantino, M.L., Shockney, L.D., Cancer rehabilitation may improve function in survivors and decrease the economic burden of cancer to individuals and society (2013) Work, 46, pp. 455-472; Mishra, S.I., Scherer, R.W., Snyder, C., Geigle, P.M., Berlanstein, D.R., Topaloglu, O., Exercise interventions on health-related quality of life for cancer survivors (2012) Cochrane Database Syst Rev, 15; Jones, L., Fitzgerald, G., Leurent, B., Round, J., Eades, J., Davis, S., Rehabilitation in advanced, progressive, recurrent cancer: A randomized controlled trial (2013) J Pain Symptom Manage, 46, pp. 315-325; Lemay, K., Wilson, K.G., Buenger, U., Jarvis, V., Fitzgibbon, E., Bhimji, K., Fear of pain in patients with advanced cancer or in patients with chronic noncancer pain (2011) Clin J Pain, 27, pp. 116-124; Silver, J., Mayer, R.S., Barriers to pain management in the rehabilitation of the surgical oncology patients (2007) J Surg Oncol, 95, pp. 427-443; De Tommaso, M., Kunz, M., Valeriani, M., Therapeutic approach to pain in neurodegenerative diseases: Current evidence and perspectives (2016) Expert Rev Neurother, pp. 1-11. , Jul 26: [Epub ahead of print]; Geroin, C., Gandolfi, M., Bruno, V., Smania, N., Tinazzi, M., Integrated approach for pain management in Parkinson disease (2016) Curr Neurol Neurosci Rep, 16, p. 28; Beiske, A.G., Loge, J.H., Rønningen, A., Svensson, E., Pain in Parkinson's disease: Prevalence and characteristics (2009) Pain, 141, pp. 173-177; Nebe, A., Ebersbach, G., Pain intensity on and off levodopa in patients with Parkinson's disease (2009) Mov Disord, 24, pp. 1233-1237; Kassubek, J., Chaudhuri, K.R., Zesiewicz, T., Surmann, E., Boroojerdi, B., Moran, K., Rotigotine transdermal system and evaluation of pain inpatients with Parkinson's disease: A post hoc analysis of the RECOVER study (2014) BMC Neurol, 14, p. 42; Tassorelli, C., De Icco, R., Alfonsi E Bartolo, M., Serrao, M., Avenali, M., Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: A placebo controlled study (2014) Parkinsonism Relat Disord, 20, pp. 1140-1144; Sophie, M., Ford, B., Management of pain in Parkinson's disease (2012) CNS Drugs, 26, pp. 937-948; Thenganatt, M.A., Jankovic, J., Treatment of dystonia (2014) Neurotherapeutics, 11, pp. 139-152; Tassorelli, C., Mancini, F., Balloni, L., Pacchetti, C., Sandrini, G., Nappi, G., Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia (2006) Mov Disord, 21, pp. 2240-2243; Queiroz, M.A.R., Chien, H.F., Sekeff-Sallem, F.A., Barbosa, E.R., Physical therapy program for cervical dystonia: A study of 20 cases (2012) Funct Neurol, 27, pp. 187-192; El Bahrawy, M.N., El Tamawy, M.S., Shalaby, N.M., Abdel Alim, A.M., Cervical Dystonia: Abnormal head posture and its relation to hand function (2009) Egypt J Neurol Psychiatry Neurosurg, 46, pp. 203-208; Angelakis, E., Liouta, E., Andreadis, N., Leonardos, A., Ktonas, P., Stavrinou, L.C., Transcranial alternating current stimulation reduces symptoms in intractable idiopathic cervical dystonia: A case study (2013) Neurosci Lett, 15, pp. 39-43; Yianni, J., Bain, P., Giladi, N., Auca, M., Gregory, R., Joint, C., Globus pallidus internus deep brain stimulation for dystonic conditions: A prospective audit (2003) Mov Disord, 18, pp. 436-442; Brettschneider, J., Kurent, J., Ludolph, A., Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease (2013) Cochrane Database Syst Rev, 6; O'Brien, T., Kelly, M., Saunders, C., Motor neuron disease: A hospice perspective (1992) BMJ, 304, pp. 471-473; Neudert, C., Oliver, D., Wasner, M., Borasio, G.D., The course of the terminal phase in patients with amyotrophic lateral sclerosis (2001) J Neurol, 248, pp. 612-616; Oliver, D., Opioid medication in the palliative care of motor neurone disease (1998) Palliat Med, 12, pp. 113-115; Forshew, D.A., Bromberg, M.B., A survey of clinicians' practice in the symptomatic treatment of ALS (2003) Amyotroph Lateral Scler Other Motor Neuron Disord, 4, pp. 258-263; Borasio, G.D., Shaw, P.J., Hardiman, O., Ludolph, A.C., Sales Luis, M.L., Silani, V., Standards of palliative care for patients with amyotrophic lateral sclerosis: Results of a European survey (2001) Amyotroph Lateral Scler Other Motor Neuron Disord, 2, pp. 159-164; Bedlack, R.S., Pastula, D.M., Hawes, J., Heydt, D., Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease (2009) Amyotroph Lateral Scler, 10, pp. 210-215; Chiò, A., Silani, V., Amyotrophic lateral sclerosis care in Italy: A nationwide study in neurological centers (2001) J Neurol Sci, 191, pp. 145-150; McClelland, S., 3rd, Bethoux, F.A., Boulis, N.M., Sutliff, M.H., Stough, D.K., Schwetz, K.M., Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: Efficacy and factors associated with pain relief (2008) Muscle Nerve, 37, pp. 396-398; Amtmann, D., Weydt, P., Johnson, K.L., Jensen, M.P., Carter, G.T., Survey of cannabis use in patients with amyotrophic lateral sclerosis (2004) Am J Hosp Palliat Care, 21, pp. 95-104; Weber, M., Goldman, B., Truniger, S., Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: A randomised, double-blind crossover trial (2010) J Neurol Neurosurg Psychiatry, 81, pp. 1135-1140; Schnakers, C., Chatelle, C., Majerus, S., Gosseries, O., De Val, M., Laureys, S., Assessment and detection of pain in noncommunicative severely brain-injured patients (2010) Expert Rev Neurother, 10, pp. 1725-1731; Schnakers, C., Vanhaudenhuyse, A., Giacino, J., Ventura, M., Boly, M., Majerus, Diagnostic accuracy of the vegetative and minimally conscious state: Clinical consensus versus standardized neurobehavioral assessment (2009) BMC Neurol, 9, p. 35; Fins, J.J., Illes, J., Bernat, J.L., Hirsch, J., Laureys, S., Murphy, E., Neuroimaging and disorders of consciousness: Envisioning an ethical research agenda (2008) Am J Bioeth, 8, pp. 3-12; Atici, S., Cinel, L., Cinel, I., Doruk, N., Aktekin, M., Akca, A., Opioid neurotoxicity: Comparison of morphine and tramadol in an experimental rat model (2004) Int J Neurosci, 114, pp. 1001-1011; Formisano, R., Vinicola, V., Penta, F., Matteis, M., Brunelli, S., Weckel, J.W., Active music therapy in the rehabilitation of severe brain injured patients during coma recovery (2001) Ann Ist Super Sanita, 37, pp. 627-630; Clemenzi, A., Tonini, L., Pacev, I., Management of spasticity with Botulinum Toxin type A (BT-A): A one-year follow up prospective study Book of Abstracts of VI World Congress for NeuroRehabilitation. Wien, 2010, 21-25 March; De Tanti, A., Zampolini, M., Pregno, S., Recommendations for clinical practice and research in Severe Brain Injury in intensive rehabilitation: The Italian Consensus Conference (2015) Eur J Phys Rehabil Med, 51, pp. 89-103; Trabucchi, M., Franzoni, S., Giraudo, F.L., (2009) Il Dolore Nelle Residenze Sanitarie Assistenziali, , Rome: Carocci Faber Editore; Phillips, T.J., Cherry, C.L., Cox, S., Marshall, S.J., Rice, A.S., Pharmacological treatment of painful HIV-associated sensory neuropathy: A systematic review and meta-analysis of randomised controlled trials (2010) PLoS One, 5; Mou, J., Paillard, F., Turnbull, B., Trudeau, J., Stoker, M., Katz, N.P., Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: A meta-analysis of the Qutenza Clinical Trials Database (2013) Pain, 154, pp. 1632-1639; Hahn, K., Arendt, G., Braun, J.S., Von Giesen, H.J., Husstedt, I.W., Maschke, M., A placebo controlled trial of gabapentin for painful HIV associated sensory neuropathy (2004) J Neurol, 251, pp. 1260-1266; Simpson, D.M., Olney, R., McArthur, J.C., Khan, A., Godbold, J., Ebel-Frommer, K., A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy (2000) Neurology, 54, pp. 2115-2119; Pullen, S.D., Chigbo, N.N., Nwigwe, E.C., Chukwuka, C.J., Amah, C.C., Idu, S.C., Physiotherapy intervention as a complementary treatment for people living with HIV/AIDS (2014) HIV AIDS, 6, pp. 99-107. , Auckl
PY - 2016
Y1 - 2016
N2 - Pain is an important non-motor symptom in several neurological diseases, such as Parkinson's disease, cervical dystonia, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness and dementia, as well as in oncology and neuroinfectivology. To overcome the lack of evidence-based data on pain management in these diseases, the Italian Consensus Conference on Pain in Neurorehabilitation (ICCPN) has defined criteria for good clinical practice among Italian neurorehabilitation professionals. Here a review of the literature (PubMed, EMBASE and gray literature) on pain characteristics, treatment and impact of pain in a neurorehabilitation setting is provided. Despite the heterogeneity of data, a consensus was reached on pain management for patients with these diseases: it is an approach originating from an analysis of the available data on pain characteristics in each disease, the evolution of pain in relation to the natural course of the disease and the impact of pain on the overall process of rehabilitation. There was unanimous consensus regarding the utility of a multidisciplinary approach to pain therapy, combining the benefits of pharmacological therapy with the techniques of physiotherapy and neurorehabilitation for all the conditions considered. While some treatments could be different depending on pathology, a progressive approach to the pharmacological treatment of pain is advisable, starting with non-opioid analgesics (paracetamol) and nonsteroidal anti-inflammatory drugs as a first-line treatment, and opioid analgesics as a second-line treatment. In cases of pain secondary to spasticity, botulinum neurotoxin, and, in some cases, intrathecal baclofen infusion should be considered. Randomized controlled trials and prospective multicenter studies aimed at documenting the efficacy of pain treatment and their risk-benefit profile are recommended for these conditions. © 2016 Edizioni Minerva Medica.
AB - Pain is an important non-motor symptom in several neurological diseases, such as Parkinson's disease, cervical dystonia, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness and dementia, as well as in oncology and neuroinfectivology. To overcome the lack of evidence-based data on pain management in these diseases, the Italian Consensus Conference on Pain in Neurorehabilitation (ICCPN) has defined criteria for good clinical practice among Italian neurorehabilitation professionals. Here a review of the literature (PubMed, EMBASE and gray literature) on pain characteristics, treatment and impact of pain in a neurorehabilitation setting is provided. Despite the heterogeneity of data, a consensus was reached on pain management for patients with these diseases: it is an approach originating from an analysis of the available data on pain characteristics in each disease, the evolution of pain in relation to the natural course of the disease and the impact of pain on the overall process of rehabilitation. There was unanimous consensus regarding the utility of a multidisciplinary approach to pain therapy, combining the benefits of pharmacological therapy with the techniques of physiotherapy and neurorehabilitation for all the conditions considered. While some treatments could be different depending on pathology, a progressive approach to the pharmacological treatment of pain is advisable, starting with non-opioid analgesics (paracetamol) and nonsteroidal anti-inflammatory drugs as a first-line treatment, and opioid analgesics as a second-line treatment. In cases of pain secondary to spasticity, botulinum neurotoxin, and, in some cases, intrathecal baclofen infusion should be considered. Randomized controlled trials and prospective multicenter studies aimed at documenting the efficacy of pain treatment and their risk-benefit profile are recommended for these conditions. © 2016 Edizioni Minerva Medica.
KW - Brain injuries
KW - Dementia
KW - Infectious disease medicine
KW - Medical oncology
KW - Motor neuron disease
KW - Movement disorders
M3 - Article
VL - 52
SP - 841
EP - 854
JO - European Journal of Physical and Rehabilitation Medicine
JF - European Journal of Physical and Rehabilitation Medicine
SN - 1973-9087
IS - 6
ER -